Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
06/2006
06/14/2006EP1668112A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and essays for making and using
06/14/2006EP1668025A2 Seneca valley virus based compositions and methods for treating disease
06/14/2006EP1032696B1 Vector for tissue-specific replication and gene expression
06/14/2006EP0956360B1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
06/14/2006CN1788088A Mutant vesicular stomatitis viruses and use thereof
06/14/2006CN1788082A Cancer target direction double gene-virus, its structure method and application thereof
06/14/2006CN1788081A Anti cancer target direction adjustable gene-virus and structure method thereof
06/14/2006CN1786177A Method of expressing bird catching arachinid toxin I and its special carrier
06/14/2006CN1786157A Virus in deactivated bioproduct and method of removing toxin in bacteria
06/14/2006CN1259418C Coding recombinant adenoviruses for iodine specific transport protein
06/14/2006CN1259106C Preparation of target gene virus medicine against cancers
06/13/2006US7060477 Protein corresponding to recombinant fungal epoxide hydrolase; use making enantiomerically pure diols and/or epoxides
06/13/2006US7060282 Equine herpesvirus (EHV) mutants are stable and have reduced virulence, which makes them very suitable for use in a live vaccine; vaccines comprising EHV mutants, DNA sequences and vectors harbouring a mutated EHV sequence, host cells transfected with the DNA
06/08/2006WO2006060314A2 Generation of replication competent viruses for therapeutic use
06/08/2006WO2006058489A1 A recombinant adeno-associated virus expressing human antisense gene cyp2j2 and its preparation methods
06/08/2006WO2006002394A3 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
06/08/2006WO2005092069A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
06/08/2006WO2005059161A3 Methods for evaluation a bacteriophage preparation
06/08/2006US20060121579 Regulated nucleic acid expression system
06/08/2006US20060121521 Cold-adapted equine influenza viruses
06/08/2006US20060121468 Viruses and virus-like particles for multiple antigen and target display
06/08/2006US20060121448 Method for inducing complete hepatitis c virus (hcv) replication in vitro
06/08/2006US20060121048 Encoding at least two full-length mannose-6-phosphate receptors in the antisense configuration, vaccines
06/08/2006US20060121013 Use of negative regulatory elements for the neurospecific expression of transgenes
06/08/2006CA2587493A1 Bacterial packaging strains usefuel for generation and production of recombinant double-stranded rna nucleocapsids and uses thereof
06/07/2006EP1666598A1 Nucleic acid and gene originating in novel hcv strain and replicon-replicating cell using the gene
06/07/2006EP1664284A1 Isolated nucleic acid molecules from the genome of citrus sudden death virus and uses thereof
06/07/2006EP1663302A2 Method for vaccination of poultry by bacteriophage lysate
06/07/2006EP1662888A2 Disinfection of foodstuffs
06/07/2006EP1051620B1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
06/07/2006EP0813606B1 Method of purification of recombinant viral vectors containing a therapeutic gene
06/07/2006EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders
06/07/2006CN1784242A A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
06/07/2006CN1782071A Recombinant mva virus and the use thereof
06/07/2006CN1258596C Leporipox-based vector vaccines
06/06/2006US7058515 Methods for making character strings, polynucleotides and polypeptides having desired characteristics
06/06/2006US7056730 Expression of heterologous genes from an IRES translational cassette in retroviral vectors
06/06/2006US7056723 High pressure homogenizing; vaccinia virus; ultrafiltration; chromatography
06/06/2006US7056696 Expression vector containing a drug-resistance gene having a destabilizing sequence as selection marker
06/06/2006US7056689 Methods of treating and detecting cancer using viruses
06/06/2006US7056502 Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids
06/06/2006CA2363493C Attenuated forms of bovine viral diarrhea virus
06/06/2006CA2116980C Chimeric and/or growth-restricted flaviviruses
06/01/2006WO2006012092A3 Safer attenuated virus vaccines with missing or diminished latency of infection
06/01/2006US20060115489 Influenza immunogen and vaccine
05/2006
05/31/2006EP1662003A2 Paramyxovirus vector for gene transfer to the cardiovascular system
05/31/2006EP1661910A1 Peptides capable of binding to titanium, silver and silicone
05/31/2006EP1660686A2 Hpv cd8+ t-cell epitopes
05/31/2006EP1660678A2 Mutant adeno-associated virus virions and methods of use thereof
05/31/2006EP1660665A2 Chimaeric vector system
05/31/2006EP1212084B1 Method of separating rotavirus variants and live attenuated rotavirus vaccine
05/31/2006EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
05/31/2006EP0888456B1 Prostate specific antigen oligo-epitope peptide
05/31/2006EP0796338B1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors
05/31/2006EP0757717B1 Papillomavirus vaccines
05/31/2006EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector
05/31/2006CN1780916A Chicken RNA polymerisate I promoter and the use thereof
05/31/2006CN1780640A Attenuated strains of vibrio cholerae and lyophilised vaccines containing same
05/31/2006CN1780632A Therapy for primary and metastatic cancers
05/31/2006CN1257976C Improved vaccines
05/31/2006CN1257973C Broad spectrum infectious chicken blader disease virus vaccine
05/31/2006CN1257751C Method for regulating replication of nonreplication adenovirus
05/30/2006US7053175 Delta -Z-TrpGlyCys- Theta -CysTyrThrSer- Omega, ( Delta represents a biotinyl radical, a biocytinyl radical, a hydrogen atom, an acetyl (CH3CO ) radical, an aliphatic chain which may contain one or two thiol, aldehyde or amine functional groups, and Z= a peptide sequence)
05/30/2006US7053046 Peptide activators of VEGF
05/30/2006US7052904 Hybrid adeno-retroviral vector for the transfection of cells
05/30/2006US7052899 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof
05/30/2006US7052830 diagnosing infection by way of binding an antibody or antigen reading frame then translating open; vaccines
05/30/2006CA2005311C Prototype felv isolates for use in disease models and vaccines
05/26/2006WO2006055331A2 Porcine reproductive and respiratory syndrome virus strains and compositions
05/26/2006WO2006053443A1 Detection of intact recombinant viruses
05/26/2006CA2587849A1 Porcine reproductive and respiratory syndrome virus strains and compositions
05/26/2006CA2579478A1 Detection of intact recombinant viruses
05/25/2006US20060111558 Recombinant infectious laryngotracheitis virus and uses thereof
05/25/2006US20060110770 Administering polypeptide of given sequence, which hydrolyzes DNA in sputum of cystic fibrosis patients
05/25/2006US20060110725 Apparatus for and method of purifying nucleic acids by different laser absorption of beads
05/25/2006US20060110406 Refrigerator-temperature stable influenza vaccine compositions
05/25/2006US20060110403 Non-human herpesviruses as vectors
05/25/2006US20060110363 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes
05/25/2006US20060110361 Methods of making viral particles having a modified cell binding activity and uses thereof
05/24/2006CN1777672A Recombinant virus comprising tumour therapeutic full-antibody gene with human constant region and its use
05/24/2006CN1777448A Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry
05/24/2006CN1775947A Recombinant adenovirus capable of expressing tomour specific apoptosis peptide, and its preparing method and use
05/24/2006CN1775946A Enhanced virus-mediated DNA transfer
05/24/2006CN1257286C Targeted adenovirus vectors for delivery of heterologous genes
05/23/2006US7049428 HCV variants
05/23/2006US7049145 Vaccinia virus MVA-E3L-knockout-mutants and use thereof
05/23/2006US7049143 Derived from the murine leukemia virus, comprises elongation factor-alpha; for gene therapy
05/23/2006US7049135 Method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
05/23/2006US7049134 Contains a rep gene open reading frame from a geminiviridae, circoviridae or genus nanovirus
05/23/2006US7049127 Method of producing infectious reovirus
05/23/2006US7049123 Deoxyribonuclease, gene encoding same and use thereof
05/23/2006US7049117 Comprises chimeric polypeptide associated with uracil phosphoribosyl transferase (UPRTase) treating proliferative and infectious diseases; gene therapy; antiproliferative agents; suicide genes
05/23/2006US7049110 Inactivation of West Nile virus and malaria using photosensitizers
05/23/2006US7048930 Expression of core-glycosylated HCV envelope proteins in yeast
05/23/2006US7048211 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
05/18/2006WO2006052813A2 Stable and filterable enveloped virus formulations
05/18/2006WO2006051396A1 Mutant porcine reproductive and respiratory syndrome virus
05/18/2006US20060105456 Method for purifying adenoviruses
05/18/2006US20060104980 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
05/18/2006US20060104964 Recombinant sequence, its preparation and use